At the 2014 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the psoriatic arthritis (PsA) working group of OMERACT (Outcome Measures in Rheumatology) presented a review of the progress made at the OMERACT 12 meeting, held in 2014. Members of the PsA OMERACT working group presented work from the Patient Involvement in Outcome Measures for PsA initiative to improve the incorporation of patient research partners in PsA outcomes research, the results of discussions within the OMERACT breakout groups, and finally the voting results. The OMERACT 12 participants had endorsed the need to update the PsA core set according to the Filter 2.0 framework. The breakout group discussions identified potential opportunities for revising the core set, including consolidating existing redundancy within the core set, improving incorporation of the patient perspective, and including disease effects such as fatigue as a core criterion. GRAPPA members of the OMERACT working group now have a program of research to update the core set with the goal of seeking endorsement at OMERACT 13, to be held in 2016.
ContributorsTillett, William Eder, Lihi Goel, Niti de Wit, Maarten Ogdie, Alexis Orbai, Ana-Maria Campbell, Willemina FitzGerald, Oliver McHugh, Neil J. Gladman, Dafna D. Strand, Vibeke Mease, Philip J.
Disease Category: Rheumatology
Disease Name: Psoriatic arthritis
Age Range: Unknown
Sex: Either
Nature of Intervention:
- Conference participants
- Commentary
- Semi structured discussion